Obesity News and Research

Latest Obesity News and Research

Surge in GLP-1 drug use for obesity coincides with drop in bariatric surgery

Researchers from Mass General Brigham and collaborators found that use of GLP-1 drugs to treat obesity more than doubled from 2022 to 2023 while rates of surgery dropped by one quarter.

26 Oct 2024

Semaglutide may reduce Alzheimer's risk in diabetics

Researchers use real-world data in the United States to evaluate the protective role of semaglutide against Alzherimer’s disease.

25 Oct 2024

The hidden effects of opioid use on the endocrine system

A new Scientific Statement released today by the Endocrine Society highlights research gaps associated with the negative effects of opioid use on the endocrine system.

25 Oct 2024

Limiting fast-food outlets can reduce childhood overweight and obesity

Research shows that restricting fast-food outlets can lower obesity rates in children, highlighting the role of planning policies in health outcomes.

25 Oct 2024

New NIH grants support research on infant development with innovative technology

Infant sleep patterns and emotional regulation are important for healthy development, but it is challenging to get real-time insights into infant behavior.

24 Oct 2024

High-intensity workouts more effective at suppressing hunger in adults

A vigorous workout does more to suppress hunger levels in healthy adults than does moderate exercise, and females may be especially susceptible to this response, according to a small study published in the Journal of the Endocrine Society.

24 Oct 2024

UNCG study links feeding practices to rapid infant weight gain

A UNC Greensboro (UNCG) study following 299 women and their infants from pregnancy to toddlerhood examined mul ple psychological, biological, and social factors in the context of infants' rapid weight gain.

24 Oct 2024

Semaglutide may lower Alzheimer's risk in type 2 diabetes patients

Researchers at the Case Western Reserve School of Medicine have found that, when compared to seven other anti-diabetic drugs, semaglutide, a popular diabetes and weight-loss drug, may lower the risk of Alzheimer's disease in people with type 2 diabetes (T2D).

24 Oct 2024

Breakthrough research reveals neural basis of eating behavior

Speaking, singing, coughing, laughing, yelling, yawning, chewing-;we use our jaws for many purposes. Each action requires a complex coordination of muscles whose activity is managed by neurons in the brain.

23 Oct 2024

Restricting fast-food outlets linked to decreased childhood obesity

Planning policies to restrict the number of new fast-food outlets leads to fewer overweight and obese children according to research led by Lancaster University.

23 Oct 2024

Rise in weight-management glucose-lowering drug prescriptions in type 1 diabetes patients

From 2010 to 2023, GLP-1RAs and SGLT2 inhibitors saw rising prescriptions in type 1 diabetes, particularly for patients with obesity and cardiorenal risks.

23 Oct 2024

Scurvy may be making a comeback amid economic strain

The scourge of scurvy, which is caused by vitamin C deficiency, may be re-emerging amid the cost of living crisis and the rise in weight loss (bariatric) surgery, suggest doctors in the journal BMJ Case Reports after treating a middle-aged man with the condition.

22 Oct 2024

Study highlights life-saving potential of access to effective obesity treatments

Expanding access to new, highly effective weight-loss medications could prevent more than 40,000 deaths a year in the United States, according to a new study led by researchers at Yale School of Public Health and the University of Florida.

22 Oct 2024

Elderberry juice boosts fat burning and gut health in overweight adults

A study found that anthocyanin-rich elderberry juice can improve gut microbiota, reduce blood glucose levels, and increase fat oxidation in overweight adults after just one week of consumption.

22 Oct 2024

Type 2 diabetes patients may benefit from reduced carbohydrate intake

Adults with type 2 diabetes on a low-carbohydrate diet may see benefits to their beta-cell function allowing them to better manage their disease and possibly discontinue medication, according to new research published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

22 Oct 2024